Clinical Trial Update: To Compare the Efficacy and Safety of HRS9531 and Placebo in Subjects With Overweight or Obese [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing HRS9531 to placebo in adults with overweight or obesity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• HRS9531

Snippet

Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. | Conditions: Overweight or Obesity | Phase 3 | Status: COMPLETED